Research teams led by UBC faculty of medicine professors have been awarded funding through the 2022 Terry Fox New Frontiers Program Project Grant to expand their research into key areas of cancer treatment.
The three B.C.-based teams are led by Drs. Amina Zoubeidi, a professor in the department of urologic sciences, Christian Steidl, a professor in the department of pathology and laboratory medicine, and Jessica McAlpine, a professor in the department of obstetrics and gynaecology.
“These teams have demonstrated that they are top researchers who are conducting leading-edge science to create really innovative projects that tackle some of the most challenging problems in cancer research,” says Dr. Jim Woodgett, Terry Fox Research Institute (TFRI) President and Scientific Director. “Each team brings together outstanding researchers with complementary skills to investigate different aspects of a given area of cancer research to find improved outcomes for patients.”
The renewed program projects will each receive $6 million over six years while the new program projects each receive $2.2 million over four years.
Renewed faculty of medicine-led projects:
Project lead: Dr. Amina Zoubeidi
Project: Targeting Tumour Plasticity in Advanced Prostate Cancer
Cancer Topic: Cancer Biology
Partner: BC Cancer
Project lead: Dr. Christian Steidl
Project: Modeling lymphoma evolution and clinical trajectory using multiomics
Cancer Topic: Precision Medicine
Partner: BC Cancer
New faculty of medicine-led project:
Project lead: Dr. Jessica McAlpine
Project: Precision Oncology for Endometrial Carcinoma Patients
Cancer Topic: Precision Medicine
Partners: BC Cancer, Vancouver General Hospital, UBC
A version of this story originally appeared on the TFRI website.